387 related articles for article (PubMed ID: 24578639)
1. Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells.
Krstic J; Santibanez JF
ScientificWorldJournal; 2014; 2014():521754. PubMed ID: 24578639
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.
Santibanez JF; Obradović H; Kukolj T; Krstić J
Dev Dyn; 2018 Mar; 247(3):382-395. PubMed ID: 28722327
[TBL] [Abstract][Full Text] [Related]
3. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
4. Stromal metalloproteinases: Crucial contributors to the tumor microenvironment.
Shimoda M; Ohtsuka T; Okada Y; Kanai Y
Pathol Int; 2021 Jan; 71(1):1-14. PubMed ID: 33074556
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-beta in invasive carcinomas (Review).
Hagedorn HG; Bachmeier BE; Nerlich AG
Int J Oncol; 2001 Apr; 18(4):669-81. PubMed ID: 11251160
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
Santibanez JF; Krstic J
Curr Protein Pept Sci; 2018; 19(12):1155-1163. PubMed ID: 29086689
[TBL] [Abstract][Full Text] [Related]
8. Role of tissue stroma in cancer cell invasion.
De Wever O; Mareel M
J Pathol; 2003 Jul; 200(4):429-47. PubMed ID: 12845611
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
10. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-β (TGF-β) Activation and Fibroblast Differentiation.
Dayer C; Stamenkovic I
J Biol Chem; 2015 May; 290(22):13763-78. PubMed ID: 25825495
[TBL] [Abstract][Full Text] [Related]
12. CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stroma.
Shukla A; Edwards R; Yang Y; Hahn A; Folkers K; Ding J; Padmakumar VC; Cataisson C; Suh KS; Yuspa SH
Oncogene; 2014 Feb; 33(7):842-50. PubMed ID: 23416981
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
14. Myeloid Cell-Derived TGFβ Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms.
Vasiukov G; Novitskaya T; Zijlstra A; Owens P; Ye F; Zhao Z; Moses HL; Blackwell T; Feoktistov I; Novitskiy SV
Cancer Res; 2020 Jun; 80(12):2628-2638. PubMed ID: 32312837
[TBL] [Abstract][Full Text] [Related]
15. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
[TBL] [Abstract][Full Text] [Related]
16. Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner.
Buenrostro D; Kwakwa KA; Putnam NE; Merkel AR; Johnson JR; Cassat JE; Sterling JA
Bone; 2018 Aug; 113():77-88. PubMed ID: 29753718
[TBL] [Abstract][Full Text] [Related]
17. Role of TGF-beta in the tumor stroma.
Naber HP; ten Dijke P; Pardali E
Curr Cancer Drug Targets; 2008 Sep; 8(6):466-72. PubMed ID: 18781893
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.
Hazelbag S; Gorter A; Kenter GG; van den Broek L; Fleuren G
Hum Pathol; 2002 Dec; 33(12):1193-9. PubMed ID: 12514788
[TBL] [Abstract][Full Text] [Related]
19. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.
Hussain S; Peng B; Cherian M; Song JW; Ahirwar DK; Ganju RK
Front Immunol; 2020; 11():598532. PubMed ID: 33414786
[TBL] [Abstract][Full Text] [Related]
20. The reactive stroma microenvironment and prostate cancer progression.
Barron DA; Rowley DR
Endocr Relat Cancer; 2012 Dec; 19(6):R187-204. PubMed ID: 22930558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
